This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Sanofi, Aventis Pharmaceuticals Inc., Sanofi-A Ventis Deutschland Gmbh. Active years: 2010-2014.
Company Filing History:


Years Active: 2010-2014
Title: The Innovations of Inventor Yuri Ivashchenko
Introduction
Yuri Ivashchenko is a notable inventor based in Hattersheim, Germany, who has made significant contributions to the field of pharmaceuticals. With four patents to his name, he has demonstrated a commitment to advancing medical treatments through innovative chemical compounds.
Latest Patents
Among his latest innovations, Yuri Ivashchenko has developed isoquinoline derivatives, specifically 6-piperidinyl-substituted isoquinoline derivatives. These compounds, described by the formula (I), are noteworthy for their potential in the treatment and prevention of diseases associated with Rho-kinase and Rho-kinase mediated phosphorylation of myosin light chain phosphatase. The applications of these derivatives aim to enhance therapeutic outcomes and offer new avenues for disease management.
Career Highlights
Throughout his career, Yuri has collaborated with prominent companies, including Sanofi and Sanofi-Aventis Deutschland GmbH, where he has applied his inventive skills to create impactful pharmaceuticals. His work in these organizations has positioned him at the forefront of medical research and innovation.
Collaborations
During his professional journey, Yuri Ivashchenko has worked alongside distinguished colleagues such as Matthias Loehn and Oliver Plettenburg. These collaborations have contributed to a rich environment of innovation and have aided in the successful development of his patented technologies.
Conclusion
Yuri Ivashchenko's contributions to the field of pharmaceuticals, particularly with his innovative isoquinoline derivatives, highlight the importance of inventors in advancing medical science. His work continues to inspire future innovations aimed at improving healthcare outcomes.